| Literature DB >> 35558013 |
Qi-Fan Wu1, Bin Zhao1, Zhi-Jin Fan1, Jia-Bao Zhao1, Xiao-Feng Guo1, Dong-Yan Yang1, Nai-Lou Zhang1, Bin Yu1, Tatiana Kalinina2, Tatiana Glukhareva2.
Abstract
3,4-Dichloroisothiazoles can induce systemic acquired resistance (SAR) to enhance plant resistance against a subsequent pathogen attack, and oxathiapiprolin exhibits excellent anti-fungal activity against oomycetes targeting at the oxysterol-binding protein. To discover novel chemicals with systemic acquired resistance and fungicidal activity, 21 novel isothiazole-thiazole derivatives were designed, synthesized and characterized according to the active compound derivatization method. Compound 6u, with EC50 values of 0.046 mg L-1 and 0.20 mg L-1 against Pseudoperonospora cubensis (Berk. et Curt.) Rostov and Phytophthora infestans in vivo, might act at the same target as oxysterol binding protein (PcORP1) of oxathiapiprolin; this result was validated by cross-resistance and molecular docking studies. The expression of the systemic acquired resistance gene pr1 was significantly up-regulated after treating with compound 6u for 24 h (43-fold) and 48 h (122-fold). These results can help the development of isothiazole-thiazole-based novel fungicides. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35558013 PMCID: PMC9090924 DOI: 10.1039/c8ra07619g
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Design of target isothiazole–thiazoles.
The structures of the target compounds 6a–6u
| Compound |
| R | R1 | Compound |
| R | R1 |
|---|---|---|---|---|---|---|---|
| 6a | 1 |
| — | 6k | 0 |
|
|
| 6b | 1 |
| — | 6l |
| ||
| 6c | 0 |
|
| 6m |
| ||
| 6d |
| 6n |
| ||||
| 6e |
| 6o | 0 |
| — | ||
| 6f |
| 6p | 0 |
| — | ||
| 6g | 0 |
|
| 6q | 0 |
| — |
| 6h |
| 6r | 0 |
| — | ||
| 6i |
| 6s | 0 |
| — | ||
| 6j |
| 6t | 0 |
| — | ||
| 6u | 0 |
| — |
Scheme 1Synthesis route of isothiazole–thiazole derivatives.
Fig. 2X-ray single crystal structure of compound 6j.
Toxicities (EC50 values) of the target compounds in vitro
| Fungi | Compd | Regression equation |
| EC50/mg L−1 |
|---|---|---|---|---|
|
| 6o |
| 0.9642 | 8.92 |
| 6s |
| 0.9839 | 7.84 | |
| Oxathiapiprolin |
| 0.9857 | 296.60 | |
| Azoxystrobin |
| 0.9251 | 185.42 | |
|
| 6a |
| 0.9917 | 15.03 |
| 6f |
| 0.9828 | 7.67 | |
| 6o |
| 0.9858 | 15.60 | |
| Oxathiapiprolin |
| 0.9944 | 1.47 | |
| Azoxystrobin |
| 0.9777 | 6.92 | |
|
| 6b |
| 0.9298 | 0.22 |
| 6c |
| 0.9284 | 0.53 | |
| 6l |
| 0.9611 | 3.83 | |
| 6r |
| 0.9582 | 17.36 | |
| Oxathiapiprolin |
| 0.9855 | 5.98 | |
| Azoxystrobin |
| 0.8375 | 4.04 |
Azoxystrobin, the data cited from the ref. 21.
Azoxystrobin, the data cited from the ref. 22.
Oomycete sensitivity in wild-type and oxathiapiprolin-resistant strains of P. capsici
| Strains | Inhibition ratio (mean ± SD) | ||
|---|---|---|---|
| 6u (10 mg L−1) | Oxathiapiprolin (10 mg L−1) | Oxathiapiprolin (1 mg L−1) | |
| LP3 (wild-type) | 32 ± 3% | 100% | 100% |
| LP3-m (oxathiapiprolin-resistant) | 12 ± 2% | 78 ± 2% | 26 ± 3% |
| LP3-h (oxathiapiprolin-resistant) | 7 ± 2% | 71 ± 5% | 17 ± 5% |
Fig. 3Molecular docking comparison results of oxathiapiprolin and compound 6u with PsORP1.
Fungicidal activity of piperidinyl-thiazoles at 100 mg L−1in vivo
| Compd | Inhibition rate (%) | |
|---|---|---|
|
|
| |
| 6a | 0 | 0 |
| 6b | 100 | 100 |
| 6c | 100 | 100 |
| 6d | 100 | 100 |
| 6e | 100 | 100 |
| 6f | 30 ± 2 | 0 |
| 6g | 0 | 0 |
| 6h | 100 | 0 |
| 6i | 40 ± 1 | 100 |
| 6j | 0 | 0 |
| 6k | 100 | 100 |
| 6l | 100 | 100 |
| 6m | 100 | 100 |
| 6n | 100 | 100 |
| 6o | 100 | 60 ± 4 |
| 6p | 100 | 100 |
| 6q | 100 | 0 |
| 6r | 100 | 100 |
| 6s | 100 | 100 |
| 6t | 80 ± 4 | 100 |
| 6u | 100 | 100 |
| Isotianil | 100 | 100 |
| Oxathiapiprolin | 100 | 100 |
The EC50 values of 6a–6u against P. cubensis in vivo
| Compd | Regression equation |
| EC50 (mg L−1) | 95% CI |
|---|---|---|---|---|
| 6a | — | — | >100 | — |
| 6b |
| 0.9808 | 0.10 | 0.01–0.70 |
| 6c |
| 0.9330 | 4.61 | 0.97–22.46 |
| 6d |
| 0.9273 | 4.71 | 0.91–23.79 |
| 6e |
| 0.9901 | 12.49 | 7.59–22.36 |
| 6f | — | — | >100 | — |
| 6g | — | — | >100 | — |
| 6h |
| 0.9901 | 12.49 | 7.59–22.36 |
| 6i | — | — | >100 | — |
| 6j | — | — | >100 | — |
| 6k |
| 0.9665 | 1.42 | 0.35–6.39 |
| 6l |
| 1.0000 | 2.02 | 1.99–2.18 |
| 6m |
| 0.9609 | 0.91 | 0.16–4.94 |
| 6n |
| 0.9998 | 1.05 | 0.93–1.24 |
| 6o |
| 0.9901 | 12.49 | 7.59–22.36 |
| 6p |
| 0.9788 | 0.11 | 0.05–0.24 |
| 6q |
| 0.9858 | 13.58 | 7.23–24.05 |
| 6r |
| 0.9253 | 3.49 | 0.62–19.46 |
| 6s |
| 1.0000 | 2.13 | 2.06–2.11 |
| 6t | — | — | — | — |
| 6u |
| 0.9621 | 0.046 | 0.016–0.13 |
| Oxathiapiprolin |
| 0.9997 | 0.0046 | 0.0042–0.0051 |
| Isotianil |
| 0.9985 | 1.01 | 0.78–1.22 |
95% confidence interval.
Not determined.
The EC50 values of 6a–6u against P. infestans in vivo
| Compd | Regression equation |
| EC50 (mg L−1) | 95% CI |
|---|---|---|---|---|
| 6a | — | — | >100 | — |
| 6b |
| 0.9634 | 0.68 | 0.21–2.10 |
| 6c |
| 0.9704 | 4.44 | 1.73–11.03 |
| 6d |
| 0.9889 | 13.00 | 7.16–22.02 |
| 6e |
| 0.9889 | 13.00 | 7.16–22.02 |
| 6f | — | — | >100 | — |
| 6g | — | — | >100 | — |
| 6h | — | — | >100 | — |
| 6i |
| 0.9662 | 4.39 | 1.67–11.19 |
| 6j | — | — | >100 | — |
| 6k |
| 0.9969 | 2.14 | 1.61–2.86 |
| 6l |
| 0.9770 | 3.66 | 1.76–8.40 |
| 6m |
| 0.9921 | 0.74 | 0.48–1.25 |
| 6n |
| 0.9352 | 0.75 | 0.17–3.47 |
| 6o | — | — | >100 | — |
| 6p |
| 0.9167 | 0.38 | 0.06–2.31 |
| 6q | — | — | >100 | — |
| 6r |
| 0.9662 | 4.39 | 1.67–11.19 |
| 6s |
| 0.9555 | 0.81 | 0.26–2.67 |
| 6t |
| 0.9050 | 1.32 | 0.22–7.80 |
| 6u |
| 0.9651 | 0.20 | 0.06–0.75 |
| Oxathiapiprolin | — | — | <0.10 | — |
| Isotianil |
| 0.9749 | 0.61 | 0.23–1.71 |
95% confidence interval.
Not determined.
Fig. 4The expressions of pr1 and npr1 after treating with 6u.
Primers used for Q-PCR
| Gene ID | Gene name | Primer-F | Primer-R |
|---|---|---|---|
| AT3G41768 |
| tgtttgatggtaactactactc | gaatgatgcctcgccagcacaga |
| AT1G64280 |
| acgaagagaacatcaccggg | cgggaagaatcgtttcccga |
| AT2G14610 |
| attttactggctattctcgatt | agttgcctcttagttgttctgcg |